MedTrace Logo

Galectin-3 in Patients With Endometriosis

NCT03212612 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2017-07-11

No results posted yet for this study

Summary

The exact cause of endometriosis is unknown ,so our study is to investigate the relationship between Galectin-3 and endometriosis by comparing between its level in healthy and endometriosis women. Also, we will measure the level of oxidative stress markers in endometrium of both healthy and endometriosis women and investigate the correlaton between them and galectin-in endometriosis women.

Conditions

  • Endometriosis

Interventions

DIAGNOSTIC_TEST

samples obtained by laparoscopy or punch biopsy for analysis by ELISA

Endometrial samples(1-2 gram) will be separated from each women during proliferative phase(days 5-15) by laparoscopy or punch biopsy and washed several times with 0.9% sterile saline solution to remove any blood from the tissues. The tissue samples will homogenized by tissue homogenizer at 40,000rpm. The supernatant extracts will be collected in Ependorf tubes and frozen at -80°C till analysis by ELISA

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • heba magdy mohammed · faculty of medicine -aasiut university

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-08-31
Primary Completion
2018-01-31
Completion
2018-04-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03212612 on ClinicalTrials.gov